Biology of epidermodysplasia verruciformis-associated HPV;Biologie der epidermodysplasia-verruciformis-assoziierten HPV

Hautarzt

Volumn 62, Issue 1, 2011, Pages 17-21

  Pfister, H ^a  

^a Institut fur Virologie   (Germany)

Author keywords

Betapapillomaviruses; Epidermodysplasia verruciformis; Immunosuppression; Psoriasis; UV light

Indexed keywords

ARTICLE; BETAPAPILLOMAVIRUS; BIOLOGY; BURN; CELL PROLIFERATION; EPIDERMODYSPLASIA VERRUCIFORMIS; GENE MUTATION; HAIR FOLLICLE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PERSISTENT VIRUS INFECTION; PSORIASIS; SOUTHERN BLOTTING; ULTRAVIOLET IRRADIATION; VIRUS CARCINOGENESIS; VIRUS REPLICATION; WART VIRUS;

ADULT; ANIMALS; BETAPAPILLOMAVIRUS; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; MICE; PAPILLOMAVIRUS INFECTIONS;

EID: 79952536121     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-010-2030-8     Document Type: Article

References (27)

1. Akgül B, Lemme W, Garcia-Escudero R et al (2005) UV-B irradiation stimulates the promoter activity of the high-risk, cutaneous human papillomavirus 5 and 8 in primary keratinocytes. Arch Virol 150:145-151 (Pubitemid 40171956)
2. Astori G, Lavergne D, Benton C et al (1998) Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 110:752-755 (Pubitemid 28194022)
3. Bernard HU, Burk RD, Chen Z et al (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401:70-79
4. Bouvard V, Baan R, Straif K et al (2009) A review of human carcinogens - Part B: biological agents. Lancet Oncol 10:321-322
5. Boxman IL, Berkhout RJ, Mulder LH et al (1997) Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 108:712-715 (Pubitemid 27192341)
6. Cronin JG, Mesher D, Purdie K et al (2008) Beta-papillomaviruses and psoriasis: an intra-patient comparison of human papillomavirus carriage in skin and hair. Br J Dermatol 159:113-119 (Pubitemid 351874505)
7. De Koning MN, Weissenborn SJ, Abeni D et al (2009) Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 90:1611-1621
8. Dell'Oste V, Azzimonti B, De Andrea M et al (2009) High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J Invest Dermatol 129:1026-1034
9. Favre M, Majewski S, Noszczyk B et al (2000) Antibodies to human papillomavirus type 5 are generated in epidermal repair processes. J Invest Dermatol 114:403-407 (Pubitemid 30415323)
10. Favre M, Orth G, Majewski S et al (1998) Psoriasis: a possible reservoir for human papillomavirus type 5, the virus associated with skin carcinomas of epidermodysplasia verruciformis. J Invest Dermatol 110:311-317 (Pubitemid 28158642)
11. Hufbauer M, Lazic D, Akgül B et al (2010) Enhanced human papillomavirus type 8 oncogene expression levels are crucial for skin tumorigenesis in transgenic mice. Virology 403:128-136
12. Köhler A, Forschner T, Meyer T et al (2007) Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol 156:1078-1080 (Pubitemid 46642848)
13. Lazarczyk M, Cassonnet P, Pons C et al (2009) The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev 73:348-370
14. Marcuzzi GP, Hufbauer M, Kasper HU et al (2009) Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding. J Gen Virol 90:2855-2864
15. Michael KM, Waterboer T, Pfister H et al (2010) Seroreactivity of 38 human papillomavirus types in epidermodysplasia verruciformis patients, relatives, and controls. J Invest Dermatol 130:841-848
16. Michael KM, Waterboer T, Sehr P et al (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLoS Pathog 4:e1000091
17. Orth G (2006) Genetics of epidermodysplasia verruciformis: Insights into host defense against papillomaviruses. Semin Immunol 18:362-374
18. Pfefferle R, Marcuzzi GP, Akgül B et al (2008) The human papillomavirus type 8 E2 protein induces skin tumors in transgenic mice. J Invest Dermatol 128:2310-2315
19. Pfister H (2003) Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 31:52-56
20. Pfister H (2008) HPV und Neoplasien der Haut. Hautarzt 59:26-30
21. Plasmeijer EI, Neale RE, Buettner PG et al (2010) Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer 126:2614-2621
22. Schaper ID, Marcuzzi GP, Weissenborn SJ et al (2005) Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65:1394-1400 (Pubitemid 40270167)
23. Stark S, Petridis AK, Ghim SJ et al (1998) Prevalence of antibodies against virus-like particles of Epidermodysplasia verruciformis-associated HPV8 in patients at risk of skin cancer. J Invest Dermatol 111:696-701 (Pubitemid 28452336)
24. Weissenborn SJ, De Koning MN, Wieland U et al (2009) Intrafamilial transmission and family-specific spectra of cutaneous betapapillomaviruses. J Virol 83:811-816
25. Weissenborn SJ, Höpfl R, Weber F et al (1999) High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA. J Invest Dermatol 113:122-126 (Pubitemid 29328170)
26. Weissenborn SJ, Nindl I, Purdie K et al (2005) Human papillomavirus-DNA loads in actinic keratoses exceed those in non-melanoma skin cancers. J Invest Dermatol 125:93-97 (Pubitemid 40981429)
27. Wolf P, Seidl H, Back B et al (2004) Increased prevalence of human papillomavirus in hairs plucked from patients with psoriasis treated with psoralen-UV-A. Arch Dermatol 140:317-324 (Pubitemid 38332483)